Posted in | News | Gold | Mining Business

Roxgold Exercises Buy Back Right and Repurchases 0.3% NSR on Séguéla Gold Project

Roxgold Inc. ("Roxgold" or the "Company") is pleased to announce that it has exercised its buy back right and repurchased a 0.3% Net Smelter Royalty (the "NSR") from an original property owner with respect to the Company's Séguéla Gold Project ("Séguéla"). In consideration for the repurchase of the NSR, Roxgold paid cash consideration of US$700,000 from cash on hand.

Roxgold exercised its rights under the royalty agreement to pre-empt an arms-length acquisition between the original property owner and an international royalty company. After close of the transaction, Séguéla continues to have a 1.2% NSR held by another original property owner under the same terms.

The Company's next permitting milestones at the Séguéla Gold Project are the receipt of the Exploitation (Mining) Permit and completion of the Mining Convention negotiation process. The Company is continuing to advance the project towards the completion of a Feasibility Study which is targeted for release within the first half of 2021.

Roxgold anticipates early works at site, including the upgrading of site access through a road improvement program and some initial site works for the accommodation village, will be commenced before the end of year. The intention of the early works activities is to enable a rapid ramp up to full construction next year.

Catalysts and Next Steps

Event Timing
Ongoing infill, expansion and satellite target drilling program at Séguéla Q4 2020
Drilling results from Boussoura Q4 2020
Underground drilling program in 55 Zone at Yaramoko Mine Complex H1 2021
Feasibility Study for Séguéla H1 2021
Séguéla construction decision H1 2021
Annual Mineral Resource & Reserve Update at Yaramoko Mine Complex (incorporating current underground drill campaign) H2 2021

Qualified Persons

Paul Criddle, FAusIMM, Chief Operating Officer for Roxgold Inc., a Qualified Person within the meaning of National Instrument 43-101, has reviewed and approved the scientific and technical disclosure contained in this news release.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.